Immucor Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Immucor

Access the complete profile.

Immucor Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325413 In-Vitro Diagnostic Substance Manufacturing
Address	3130 Gateway Drive P.o. Box 5625 Norcross, GA 30091

Note: Revenues for privately held companies are statistical evaluations.


Immucor's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Immucor's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Immucor is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Immucor Annual Revenue and Growth Rate

Immucor	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Immucor's revenues are gauged from an analysis of company filings.

Immucor's Income Statement (based on Industry Averages)

Immucor P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Immucor is developing and marketing. Immucor doesn't have any recent trademark applications, indicating Immucor is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ORGAN-I Medical and scientific research services, namely, assessing the immune response to transplantation using genomic or proteomic based assays	08/05/2016
KSORT Medical and scientific research services, namely, assessing the immune response to kidney transplantation using genomic or proteomic based assays	08/05/2016
CSORT Medical and scientific research services, namely, assessing the immune response to cardiac transplantation using genomic or proteomic based assays	08/05/2016

See all trademarks and details in the Full Report.

Latest News Releases

Date	Event
Jun 19, 2017	Immucor, Inc. Announces Exchange Offer
May 31, 2017	Immucor and ATC A.S. Partner for Turkish Registry HLA Typing
Apr 11, 2017	Immucor to Host Debt Investor Conference Call on Friday, April 21, 2017
Feb 17, 2017	Immucor Announces the Launch of Pak Lx RUO in the United States
Feb 14, 2017	Immucor Launches MIA FORA NGS FLEX HLA Typing Assay
Jan 17, 2017	Immucor to Host Debt Investor Conference Call on Tuesday, February 7, 2017

Market Share of Immucor's Largest Competitors

A competitive analysis shows these companies are in the same general field as Immucor, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Immucor. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
UCB	Smyrna, GA	100
IMMUCOR	Norcross, GA	39
ACELLA PHARMACEUTICALS & AVION PHARMACEUTICALS	Alpharetta, GA	27
ALORA PHARMACEUTICALS	Alpharetta, GA	21
SEBELA PHARMACEUTICALS	Roswell, GA	12
CLEARSIDE BIOMEDICAL	Alpharetta, 2Q	2

Future Competition: Immucor's Fastest Growing Competitors

These companies are in the same general field as Immucor and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)